Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Safety Information Added to the Myfortic Prescribing Information
Novartis notified healthcare professionals that cases of Pure Red Cell Aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil (MMF) in combination with other immunosuppressive agents. In the body, MMF is converted to mycophenolic acid (MPA), the active ingredient in Myfortic. Pure Red Cell Aplasia is a type of anemia where the bone marrow slows or stops production of red blood cells. The WARNINGS and ADVERSE REACTIONS sections of the Myfortic Prescribing Information have been revised to reflect this new safety information. For more information, please visit: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm181306.htm
Learn More

Rivistigmine (Exelon) Linked to Increased Risk of Fainting and Low Heart Rate
A recent study in the Archives of Internal Medicine suggests that the risk of fainting and low heart rate is increased in patients who take cholinesterase inhibitors such donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon) for the treatment of dementia. The study also identified that patients on these medications have an increased risk of pacemaker insertion and hip fractures, which are common complications of low heart rate and fainting. For more information, please visit: http://archinte.ama-assn.org/cgi/content/abstract/169/9/867
Learn More

Date Published Title Drug Source
2009-09-04 Safety Information Added to the Myfortic Prescribing Information Mycophenolic Acid Manufacturer
2009-08-28 Rivistigmine (Exelon) Linked to Increased Risk of Fainting and Low Heart Rate Exelon MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Atorvastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Fluvastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Lovastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Pravastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Rosuvastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Simvastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Niacin and Simvastatin MediGuard CRT
2009-08-28 Study Supports Link Between Statins and Muscle Pain and Weakness Atorvastatin and Amlodipine MediGuard CRT
2009-08-28 Warning About Serious Skin Reactions with Use of Intelence Etravirine Manufacturer
2009-08-28 Updated Prescribing Information Available Montelukast FDA
2009-08-28 Updated Prescribing Information Available Zileuton FDA
2009-08-28 Updated Prescribing Information Available Zafirlukast FDA
2009-08-27 Reminder Alert: Three Lots of Levemir Insulin Reported Stolen Insulin Detemir FDA
2009-08-27 Tamsulosin (Flomax) Linked to Serious Eye Complications Following Cataract Surgery Tamsulosin MediGuard CRT
2009-08-27 Two Recent Studies Support Safety Concerns of Erythropoiesis Stimulating Agent Use in Cancer Patient Epoetin Alfa MediGuard CRT
2009-08-27 Two Recent Studies Support Safety Concerns of Erythropoiesis Stimulating Agent Use in Cancer Patient Darbepoetin Alfa MediGuard CRT
2009-08-27 Donepezil (Aricept) Linked to Increased Risk of Fainting and Low Heart Rate Donepezil MediGuard CRT
2009-08-27 Galantamine (Razadyne) Linked to Increased Risk of Fainting and Low Heart Rate Galantamine MediGuard CRT